3rd Annual International Prostate Cancer and Urologic Oncology Symposium

SAVE THE DATE – DECEMBER 13 – 15, 2018

Stern Auditorium
1468 Madison Avenue
New York, NY

Course Director

Ash Tewari, MBBS, MCh

Course Co-Director

Ketan K. Badani, MD

Faculty Spotlight

Meet the Course Director
Dr. Ash Tewari, MBBS, MCh

Dr. Ash Tewari is an innovator in the fields of robotic prostate cancer surgery and prostate cancer treatment.  He also designated various grades of nerve-sparing utilizing information from MRIs, allowing for incremental nerve-sparing particularly in cases that would have not previously qualified without this graded approach. He has described traction free and athermal nerve-sparing techniques and developed an innovative Detrusor wrap technique for early urinary continence.

Working with genitourinary pathologists and scientists from the University of Hamburg, he is currently evaluating the role of MRI-guided NeuroSAFE ® and sphinctersafe approaches in expanding opportunities for nerve-sparing.  An active researcher and surgeon scientist, he is one of only a few robotic surgeons to be awarded a NIH R01 grant, for the investigation of real-time tissue identification during prostate cancer surgery.

Course Co-Director
Ketan Badani, MD
Icahn School of Medicine at Mount Sinai

Ketan Badani is the Vice Chairman of Urology and Director of the Robotic Surgery Program and Kidney Cancer Program at the Mount Sinai Health System in New York City. He has been the director of several large multi-organ robotic surgery programs over the past 10 years, and has an experience of over 5,000 robotic surgeries to date.

Dr. Badani has been involved since the early days of robotic surgery and in 2004 led one of the initial teams that developed robotic kidney surgery. He has published extensively on the topic with over 150 peer reviewed manuscripts and demonstrated his surgical techniques in over 20 countries. A true “surgeon-scientist”, Dr. Badani has a robust clinical and basic science research laboratory to study genomic profiles and patient derived Xenograft models of renal cell carcinoma subtypes.

Inaugural Symposiums:
Immunotherapy of Urologic & GU Cancers and
World Consortium on Advanced Urologic Cancer